IMMUTEP LIMITED - AMER
2.0500
07-10月-24 15:59:57
15 分の遅延
株式
0.0000
0.00%
本日の幅
2.0200 - 2.0900
ISIN
N/A
ソース
NASDAQ
-
17 4 2024 08:00:01 提供 Nasdaq GlobeNewswire
-
Immutep Announces First Clinical Data from 90mg Dosing of Efti
05 3 2024 08:00:00 提供 Nasdaq GlobeNewswire
-
Immutep Quarterly Activities Report Q2 FY24
30 1 2024 08:00:00 提供 Nasdaq GlobeNewswire
-
04 1 2024 08:00:00 提供 Nasdaq GlobeNewswire
-
21 12 2023 08:00:00 提供 Nasdaq GlobeNewswire
-
Immutep Receives A$2.6 million R&D Tax Incentive from French Government
07 12 2023 08:00:00 提供 Nasdaq GlobeNewswire
-
Immutep Announces Site Expansion for INSIGHT-003 Phase I Trial
22 11 2023 08:00:00 提供 Nasdaq GlobeNewswire
-
09 11 2023 08:00:00 提供 Nasdaq GlobeNewswire
-
06 11 2023 08:00:01 提供 Nasdaq GlobeNewswire
-
03 11 2023 12:00:00 提供 Nasdaq GlobeNewswire
-
Immutep to Participate in November Investor Events
02 11 2023 08:00:00 提供 Nasdaq GlobeNewswire
-
Immutep Quarterly Activities Report Q1 FY24
31 10 2023 08:00:00 提供 Nasdaq GlobeNewswire
-
Immutep receives ~A$1.13 million R&D Tax Incentive
25 10 2023 08:00:00 提供 Nasdaq GlobeNewswire
-
Immutep Reports Promising Clinical Data from INSIGHT-003 Trial at ESMO Congress 2023
24 10 2023 08:00:00 提供 Nasdaq GlobeNewswire
-
23 10 2023 08:00:00 提供 Nasdaq GlobeNewswire
-
Immutep Announces Publication of Abstracts at ESMO Congress 2023
16 10 2023 08:00:00 提供 Nasdaq GlobeNewswire
-
03 10 2023 08:00:00 提供 Nasdaq GlobeNewswire
-
21 9 2023 08:00:00 提供 Nasdaq GlobeNewswire
-
Immutep to Participate in September Investor Conferences
05 9 2023 09:00:00 提供 Nasdaq GlobeNewswire
-
Immutep Receives Positive Scientific Advice from European Medicines Agency
01 8 2023 08:00:02 提供 Nasdaq GlobeNewswire